Galantamine is an oral medication used to treat patients with Alzheimer's disease.
cholinesterase inhibitors
Mild to moderately severe dementia in Alzheimer’s disease BY MOUTH USING IMMEDIATE-RELEASE MEDICINES Adult: Initially 4 mg twice daily for 4 weeks, increased to 8 mg twice daily for at least 4 weeks; maintenance 8-12 mg twice daily BY MOUTH USING MODIFIED-RELEASE CAPSULES Adult: Initially 8 mg once daily for 4 weeks, increased to 16 mg once daily for at least 4 weeks; maintenance 16-24 mg daily.
Avoid in gastro-intestinal obstruction . avoid in urinary outflow obstruction . avoid whilst recovering from bladder surgery . avoid whilst recovering from gastrointestinal surgery . cardiac disease . chronic obstructive pulmonary disease . congestive heart failure . electrolyte disturbances . history of seizures . history of severe asthma . pulmonary infection . sick sinus syndrome . supraventricular conduction abnormalities . susceptibility to peptic ulcers . unstable angina.
Common or very common Abdominal pain . bradycardia . decreased appetite . depression . diarrhoea . dizziness . dyspepsia . fatigue . hallucination . headache . hypertension . malaise . muscle spasm . nausea . syncope . tremor . vomiting . weight loss Uncommon Arrhythmias . blurred vision . dehydration . first-degree AV block . flushing . hypersomnia . hypotension . muscular weakness . palpitation . paraesthesia . retching . seizures . sweating . taste disturbance . tinnitus Rare Acute generalized exanthematous pustulosis . erythema multiforme . exacerbation of Parkinson’s disease . hepatitis . Stevens-Johnson syndrome
PREGNANCY Use with caution?toxicity in animal studies. BREAST FEEDING Avoid?no information available.
.png&w=384&q=75)